Exhibit B AGREEMENT REGARDING THE JOINT FILING OF SCHEDULE 13GJoint Filing Agreement • February 12th, 2020 • Polaris Venture Partners V, L.P. • Pharmaceutical preparations
The undersigned, being duly authorized thereunto, hereby execute this agreement as an exhibit to this Schedule 13G to evidence the agreement of the below-named parties, in accordance with the rules promulgated pursuant to the Securities Exchange Act of 1934, to file this Schedule jointly on behalf of each such party.
Exhibit A AGREEMENT REGARDING THE JOINT FILING OF SCHEDULE 13DAgreement Regarding the Joint Filing of Schedule 13d • May 22nd, 2015 • Polaris Venture Partners V, L.P. • Biological products, (no disgnostic substances)
The undersigned, being duly authorized thereunto, hereby execute this agreement as an exhibit to this Schedule 13D to evidence the agreement of the below-named parties, in accordance with the rules promulgated pursuant to the Securities Exchange Act of 1934, to file this Schedule jointly on behalf of each such party.
Exhibit A AGREEMENT REGARDING THE JOINT FILING OF SCHEDULE 13DAgreement Regarding the Joint Filing of Schedule 13d • September 10th, 2015 • Polaris Venture Partners V, L.P. • Pharmaceutical preparations
The undersigned, being duly authorized thereunto, hereby execute this agreement as an exhibit to this Schedule 13D to evidence the agreement of the below-named parties, in accordance with the rules promulgated pursuant to the Securities Exchange Act of 1934, to file this Schedule jointly on behalf of each such party.
Exhibit A AGREEMENT REGARDING THE JOINT FILING OF SCHEDULE 13DAgreement Regarding the Joint Filing of Schedule 13d • February 16th, 2016 • Polaris Venture Partners V, L.P. • Biological products, (no disgnostic substances)
The undersigned, being duly authorized thereunto, hereby execute this agreement as an exhibit to this Schedule 13D to evidence the agreement of the below-named parties, in accordance with the rules promulgated pursuant to the Securities Exchange Act of 1934, to file this Schedule jointly on behalf of each such party.
Exhibit A AGREEMENT REGARDING THE JOINT FILING OF SCHEDULE 13DAgreement Regarding the Joint Filing of Schedule 13d • December 21st, 2018 • Polaris Venture Partners V, L.P. • Biological products, (no disgnostic substances)
The undersigned, being duly authorized thereunto, hereby execute this agreement as an exhibit to this Schedule 13D to evidence the agreement of the below-named parties, in accordance with the rules promulgated pursuant to the Securities Exchange Act of 1934, to file this Schedule jointly on behalf of each such party.
Exhibit A AGREEMENT REGARDING THE JOINT FILING OF SCHEDULE 13DAgreement Regarding the Joint Filing of Schedule 13d • May 14th, 2015 • Polaris Venture Partners V, L.P. • Surgical & medical instruments & apparatus
The undersigned, being duly authorized thereunto, hereby execute this agreement as an exhibit to this Schedule 13D to evidence the agreement of the below-named parties, in accordance with the rules promulgated pursuant to the Securities Exchange Act of 1934, to file this Schedule jointly on behalf of each such party.
Exhibit A AGREEMENT REGARDING THE JOINT FILING OF SCHEDULE 13GJoint Filing Agreement • February 14th, 2019 • Polaris Venture Partners V, L.P. • Services-computer programming, data processing, etc.
The undersigned, being duly authorized thereunto, hereby execute this agreement as an exhibit to this Schedule 13G to evidence the agreement of the below-named parties, in accordance with the rules promulgated pursuant to the Securities Exchange Act of 1934, to file this Schedule jointly on behalf of each such party.
Exhibit A AGREEMENT REGARDING THE JOINT FILING OF SCHEDULE 13DJoint Filing Agreement • September 29th, 2017 • Polaris Venture Partners V, L.P. • Pharmaceutical preparations
The undersigned, being duly authorized thereunto, hereby execute this agreement as an exhibit to this Schedule 13D to evidence the agreement of the below-named parties, in accordance with the rules promulgated pursuant to the Securities Exchange Act of 1934, to file this Schedule jointly on behalf of each such party.
Exhibit A AGREEMENT REGARDING THE JOINT FILING OF SCHEDULE 13GJoint Filing Agreement • February 12th, 2021 • Polaris Venture Partners V, L.P. • Surgical & medical instruments & apparatus
The undersigned, being duly authorized thereunto, hereby execute this agreement as an exhibit to this Schedule 13G to evidence the agreement of the below-named parties, in accordance with the rules promulgated pursuant to the Securities Exchange Act of 1934, to file this Schedule and all amendments thereto jointly on behalf of each such party.
Exhibit A AGREEMENT REGARDING THE JOINT FILING OF SCHEDULE 13DJoint Filing Agreement • February 4th, 2019 • Polaris Venture Partners V, L.P. • Pharmaceutical preparations
The undersigned, being duly authorized thereunto, hereby execute this agreement as an exhibit to this Schedule 13D Amendment No. 3 to evidence the agreement of the below-named parties, in accordance with the rules promulgated pursuant to the Securities Exchange Act of 1934, to file this Amendment No. 3 jointly on behalf of each such party.
Exhibit A AGREEMENT REGARDING THE JOINT FILING OF SCHEDULE 13DAgreement Regarding the Joint Filing of Schedule 13d • July 7th, 2016 • Polaris Venture Partners V, L.P. • Pharmaceutical preparations
The undersigned, being duly authorized thereunto, hereby execute this agreement as an exhibit to this Schedule 13D to evidence the agreement of the below-named parties, in accordance with the rules promulgated pursuant to the Securities Exchange Act of 1934, to file this Schedule jointly on behalf of each such party.
Exhibit A AGREEMENT REGARDING THE JOINT FILING OF SCHEDULE 13DJoint Filing Agreement • April 12th, 2018 • Polaris Venture Partners V, L.P. • Pharmaceutical preparations
The undersigned, being duly authorized thereunto, hereby execute this agreement as an exhibit to this Schedule 13D to evidence the agreement of the below-named parties, in accordance with the rules promulgated pursuant to the Securities Exchange Act of 1934, to file this Schedule jointly on behalf of each such party.
AGREEMENT REGARDING THE JOINT FILING OF SCHEDULE 13DAgreement Regarding the Joint Filing of Schedule 13d • February 14th, 2019 • Polaris Venture Partners V, L.P. • Pharmaceutical preparations
This Schedule 13D was executed pursuant to a Power of Attorney. Note that copies of the applicable Powers of Attorney are already on file with the appropriate agencies.
Exhibit A AGREEMENT REGARDING THE JOINT FILING OF SCHEDULE 13DAgreement Regarding the Joint Filing of Schedule 13d • February 14th, 2019 • Polaris Venture Partners V, L.P. • Biological products, (no disgnostic substances)
The undersigned, being duly authorized thereunto, hereby execute this agreement as an exhibit to this Schedule 13D to evidence the agreement of the below-named parties, in accordance with the rules promulgated pursuant to the Securities Exchange Act of 1934, to file this Schedule jointly on behalf of each such party.
Exhibit A AGREEMENT REGARDING THE JOINT FILING OF SCHEDULE 13DJoint Filing Agreement • May 3rd, 2018 • Polaris Venture Partners V, L.P. • Pharmaceutical preparations
The undersigned, being duly authorized thereunto, hereby execute this agreement as an exhibit to this Schedule 13D Amendment No. 2 to evidence the agreement of the below-named parties, in accordance with the rules promulgated pursuant to the Securities Exchange Act of 1934, to file this Schedule jointly on behalf of each such party.
JOINT FILING AGREEMENTJoint Filing Agreement • August 20th, 2021 • Polaris Venture Partners V, L.P. • Biological products, (no disgnostic substances)
The undersigned hereby agree that the foregoing statement on Schedule 13D is filed on behalf of each of the undersigned, and any amendments thereto executed by the undersigned shall be filed on behalf of each of the undersigned without the necessity of filing any additional joint filing agreement. The undersigned acknowledge that each is responsible for the timely filing of such statement on Schedule 13D and any amendments thereto, and for the completeness and accuracy of the information concerning him, her or it contained therein, but shall not be responsible for the completeness or accuracy of the information concerning the others of the undersigned, except to the extent that it knows or has reason to believe that such information is inaccurate or incomplete. This Joint Filing Agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument.
Exhibit A AGREEMENT REGARDING THE JOINT FILING OF SCHEDULE 13DAgreement Regarding the Joint Filing of Schedule 13d • July 17th, 2019 • Polaris Venture Partners V, L.P. • Biological products, (no disgnostic substances)
The undersigned, being duly authorized thereunto, hereby execute this agreement as an exhibit to this Schedule 13D to evidence the agreement of the below-named parties, in accordance with the rules promulgated pursuant to the Securities Exchange Act of 1934, to file this Schedule jointly on behalf of each such party.
Exhibit A AGREEMENT REGARDING THE JOINT FILING OF SCHEDULE 13DAgreement Regarding the Joint Filing of Schedule 13d • July 17th, 2019 • Polaris Venture Partners V, L.P. • Biological products, (no disgnostic substances)
The undersigned, being duly authorized thereunto, hereby execute this agreement as an exhibit to this Schedule 13D to evidence the agreement of the below-named parties, in accordance with the rules promulgated pursuant to the Securities Exchange Act of 1934, to file this Schedule jointly on behalf of each such party.
AGREEMENT REGARDING THE JOINT FILING OF SCHEDULE 13DAgreement Regarding the Joint Filing of Schedule 13d • October 11th, 2013 • Polaris Venture Partners V, L.P. • Biological products, (no disgnostic substances)
The undersigned, being duly authorized thereunto, hereby execute this agreement as an exhibit to this Schedule 13D to evidence the agreement of the below-named parties, in accordance with the rules promulgated pursuant to the Securities Exchange Act of 1934, to file this Schedule jointly on behalf of each such party.
Exhibit A AGREEMENT REGARDING THE JOINT FILING OF SCHEDULE 13GJoint Filing Agreement • February 7th, 2018 • Polaris Venture Partners V, L.P. • Pharmaceutical preparations
The undersigned, being duly authorized thereunto, hereby execute this agreement as an exhibit to this Schedule 13G to evidence the agreement of the below-named parties, in accordance with the rules promulgated pursuant to the Securities Exchange Act of 1934, to file this Schedule jointly on behalf of each such party.
AGREEMENT REGARDING THE JOINT FILING OF SCHEDULE 13DAgreement Regarding the Joint Filing of Schedule 13d • April 21st, 2014 • Polaris Venture Partners V, L.P. • Pharmaceutical preparations
The undersigned, being duly authorized thereunto, hereby execute this agreement as an exhibit to this Schedule 13D to evidence the agreement of the below-named parties, in accordance with the rules promulgated pursuant to the Securities Exchange Act of 1934, to file this Schedule jointly on behalf of each such party.
Exhibit A AGREEMENT REGARDING THE JOINT FILING OF SCHEDULE 13DJoint Filing Agreement • February 14th, 2014 • Polaris Venture Partners V, L.P. • Biological products, (no disgnostic substances)
The undersigned, being duly authorized thereunto, hereby execute this agreement as an exhibit to this Schedule 13D to evidence the agreement of the below-named parties, in accordance with the rules promulgated pursuant to the Securities Exchange Act of 1934, to file this Schedule jointly on behalf of each such party.
AGREEMENT REGARDING THE JOINT FILING OF SCHEDULE 13DJoint Filing Agreement • February 12th, 2020 • Polaris Venture Partners V, L.P. • Pharmaceutical preparations
The undersigned, being duly authorized thereunto, hereby execute this agreement as an exhibit to this Schedule 13D Amendment No. 4 to evidence the agreement of the below-named parties, in accordance with the rules promulgated pursuant to the Securities Exchange Act of 1934, to file this Amendment No. 4 jointly on behalf of each such party.
Exhibit A AGREEMENT REGARDING THE JOINT FILING OF SCHEDULE 13DAgreement Regarding the Joint Filing of Schedule 13d • February 14th, 2019 • Polaris Venture Partners V, L.P. • Pharmaceutical preparations
The undersigned, being duly authorized thereunto, hereby execute this agreement as an exhibit to this Schedule 13D to evidence the agreement of the below-named parties, in accordance with the rules promulgated pursuant to the Securities Exchange Act of 1934, to file this Schedule jointly on behalf of each such party.
Exhibit A AGREEMENT REGARDING THE JOINT FILING OF SCHEDULE 13DJoint Filing Agreement • February 16th, 2016 • Polaris Venture Partners V, L.P. • Surgical & medical instruments & apparatus
The undersigned, being duly authorized thereunto, hereby execute this agreement as an exhibit to this Schedule 13D to evidence the agreement of the below-named parties, in accordance with the rules promulgated pursuant to the Securities Exchange Act of 1934, to file this Schedule jointly on behalf of each such party.
Exhibit A AGREEMENT REGARDING THE JOINT FILING OF SCHEDULE 13GJoint Filing Agreement • February 12th, 2020 • Polaris Venture Partners V, L.P. • Services-computer programming, data processing, etc.
The undersigned, being duly authorized thereunto, hereby execute this agreement as an exhibit to this Schedule 13G to evidence the agreement of the below-named parties, in accordance with the rules promulgated pursuant to the Securities Exchange Act of 1934, to file this Schedule jointly on behalf of each such party.
Exhibit A AGREEMENT REGARDING THE JOINT FILING OF SCHEDULE 13DJoint Filing Agreement • July 17th, 2019 • Polaris Venture Partners V, L.P. • Pharmaceutical preparations
The undersigned, being duly authorized thereunto, hereby execute this agreement as an exhibit to this Schedule 13D to evidence the agreement of the below-named parties, in accordance with the rules promulgated pursuant to the Securities Exchange Act of 1934, to file this Schedule jointly on behalf of each such party.
AGREEMENT REGARDING THE JOINT FILING OF SCHEDULE 13DAgreement Regarding the Joint Filing of Schedule 13d • May 5th, 2014 • Polaris Venture Partners V, L.P. • Pharmaceutical preparations
The undersigned, being duly authorized thereunto, hereby execute this agreement as an exhibit to this Schedule 13D to evidence the agreement of the below-named parties, in accordance with the rules promulgated pursuant to the Securities Exchange Act of 1934, to file this Schedule jointly on behalf of each such party.
Exhibit A AGREEMENT REGARDING THE JOINT FILING OF SCHEDULE 13DJoint Filing Agreement • February 14th, 2019 • Polaris Venture Partners V, L.P. • Surgical & medical instruments & apparatus
The undersigned, being duly authorized thereunto, hereby execute this agreement as an exhibit to this Schedule 13D to evidence the agreement of the below-named parties, in accordance with the rules promulgated pursuant to the Securities Exchange Act of 1934, to file this Schedule jointly on behalf of each such party.
Exhibit A AGREEMENT REGARDING THE JOINT FILING OF SCHEDULE 13DAgreement Regarding the Joint Filing of Schedule 13d • May 14th, 2015 • Polaris Venture Partners V, L.P. • Biological products, (no disgnostic substances)
The undersigned, being duly authorized thereunto, hereby execute this agreement as an exhibit to this Schedule 13D to evidence the agreement of the below-named parties, in accordance with the rules promulgated pursuant to the Securities Exchange Act of 1934, to file this Schedule jointly on behalf of each such party.
